Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 22, 2022
- Accession no.
- 0000899243-22-007203
- Filed
- Feb 22, 2022
- Trade date
- Feb 17-18, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $995.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2022 | Common Stock | FTax withholdingDisposed | −3,439 | $232.51 | −$799,601.89 | 53,999 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −986 | $229.22F2,F3 | −$226,010.92 | 53,013 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −1,303 | $230.05F3,F4 | −$299,755.15 | 51,710 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −385 | $231.01F3,F5 | −$88,938.85 | 51,325 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −600 | $231.85F3,F6 | −$139,110 | 50,725 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −1,038 | $233.27F3,F7 | −$242,134.26 | 49,687 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60).
Referenced by the price of 1 transaction in Table I.
- F3
Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50).
Referenced by the price of 1 transaction in Table I.